Early detection is the key to better, more effective breast cancer treatments. We know that the earlier breast cancer is detected, the greater the chance of better outcomes for the individual. Currently, the cornerstone of early detection is regular breast screening through state-based services. However, breast screening in younger women (those aged 40 years or under) is less effective due to the density of young breast tissue.
Understanding more about who may be at high risk of developing breast cancer (without a family history of the disease) will enable those groups to be targeted more effectively for screening or other early detection programs.
Early detection research we fund investigates:
- Developing a blood test for the early detection of breast cancer
- Identifying genes associated with an increased risk of developing breast cancer Improving the quality and effectiveness of breast screening.